AREVF

AREV Life Sciences Global Corp. AREVF

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode AREVF MGWFF GPFT ABTI GRVE INQD AQSZF AGFAF CSTF VIBEF
6M 0.00 % -60.30 % -40.00 % -84.62 % 114.71 % 0.00 % -30.00 % 0.00 % 0.00 % 35.40 %
YTD 0.00 % -42.74 % -35.71 % -93.33 % -63.12 % 0.00 % -46.15 % 0.00 % 900.00 % -31.37 %
1Y 0.00 % -62.90 % -30.77 % -97.78 % 11.33 % 0.00 % -77.17 % 0.00 % 900.00 % -30.00 %
3Y -87.56 % -83.61 % -95.11 % -99.70 % -89.05 % -98.50 % -94.81 % -93.61 % -100.00 % 212 121 112.12 %
5Y -54.75 % -96.03 % -98.84 % -99.97 % -92.39 % -96.43 % -97.63 % -99.98 % -100.00 % 8 333 233.33 %
10Y -99.24 % -99.25 % -77.50 % -99.99 % -89.98 % -99.98 % -99.49 % -99.99 % -100.00 % 7 276 407.28 %
From the beginning -99.24 % -99.25 % -77.50 % -99.87 % -87.98 % -99.99 % -99.49 % -99.99 % -100.00 % 7 276 407.28 %

Dividend